Cutting-Edge Company, reveal23, Launches Genetic Cancer Risk Screening Services

reveal23 is excited to announce the launch of its online genetic cancer risk screening services, including a wide range of convenient and affordable testing kits that target specific DNA-related cancers. reveal23 products offer predisposition profiling for 94 genes and over 145 cancers and health conditions.

Pomona, United States - March 8, 2017 /PressCable/ —

On the forefront of genetic cancer testing, reveal23 launches their online store of cancer risk testing kits.

Pomona, CA – reveal23 is excited to announce the launch of its online genetic cancer risk screening services, which includes a wide range of convenient and affordable testing kits that target specific DNA-related cancers. In fact, reveal23 products offer predisposition profiling for 94 genes and over 145 cancers and health conditions.

Purpose of Genetic Testing

Cancer may be caused by a variety of risk factors; some of these are under a person’s control, such as lifestyle habits, but others, such as DNA, are not. Inherited genetic mutations play a major role in approximately five to ten percent of all cancers. If a person has a family member who has cancer, he or she may have an increased risk of developing cancer, though a family history of cancer is not a guarantee of cancer in future generations.

Genetic testing is a tool used to identify those hereditary mutations in DNA that may indicate a predisposition for certain cancers or other health conditions. Once a person is well informed of his or her cancer risk, he or she can take the necessary preventative steps to support a healthy future.

reveal23 Testing Products

reveal23 offers the following inherited cancer risk testing products for men and women:

● W25 – Women’s Hereditary Breast and Ovarian – Analysis of 25 genes to determine predisposition for breast cancer, ovarian cancer, and Lynch and Cowden syndromes ● W35 – Women’s Wellness – Analysis of 35 genes to determine predisposition for breast, ovarian, lung, colorectal, bladder, uterine (endometrial), and pancreatic cancers, as well as Lynch and Cowden syndromes. ● W75 – Women’s Wellness Plus – Analysis of 75 genes to determine predisposition for the cancers and conditions mentioned above, as well as leukemia, melanoma, liver, endocrine, stomach, esophagus, kidney, and gastrointestinal cancers. ● M35 – Men’s Wellness – Analysis of 35 genes to determine predisposition for prostate, lung, liver, colorectal, pancreas, and stomach cancers. ● M72 – Men’s Wellness Plus – Analysis of 72 genes to determine predisposition for prostate, lung, liver, colorectal, pancreas, stomach, breast, kidney, esophagus, gastrointestinal and bladder cancers, as well as leukemia and melanoma, and Lynch and Cowden syndromes. ● MW94 – Total Wellness for Men and Women – Analysis of 94 genes to determine predisposition for over 145 conditions.

How It Works

Making important decisions about one’s health should never be complicated, which is why the reveal23 process involves just a few simple steps:

1. Create an account and purchase a kit online at https://reveal23.com/shop/. Once the order is approved by a reveal23 physician, the kit will be shipped out. 2. Once the kit is received, provide a saliva sample using the collection kit, activate it on your reveal23 account, and ship it back (free of charge!). 3. Get notified once results are ready, securely review the results online, and make plans to discuss the results with a physician.

There is no need to go through life in fear of cancer. Leading a healthy lifestyle is a person’s most effective method of cancer prevention and being well-informed about family health history is another. The more a person knows, the best he or she can safeguard their health.

With reveal23’s genetic testing kit, individuals can raise their own awareness about any potential inherited cancer-predisposing mutations.

About the Company

Detecting cancer early improves the odds of survival. reveal23 is on the forefront of genetic cancer screening technology, providing a revolutionary service that analyzes 94 genes, including BRCA1 and BRCA2, to assess a person’s risk for hereditary cancers, including, but not limited to, breast, ovarian, pancreatic, and colorectal cancer, as well as other health conditions.

###

Contact Info:
Name: Arineh Vartanian
Organization: Foundation Laboratory
Address: 1716 W Holt Ave, Pomona, California 91768, United States
Phone: +1-909-242-5969

For more information, please visit https://reveal23.com/

Source: PressCable

Release ID: 175946